These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28496698)

  • 21. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis.
    Waranugraha Y; Rizal A; Setiawan D; Aziz IJ
    Indian Pacing Electrophysiol J; 2021; 21(2):101-111. PubMed ID: 33548449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
    Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
    Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.
    Tolosana JM; Trucco E; Khatib M; Doltra A; Borras R; Castel MÁ; Berruezo A; Arbelo E; Sitges M; Matas M; Guasch E; Brugada J; Mont L
    Eur J Heart Fail; 2013 Dec; 15(12):1412-8. PubMed ID: 23845796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
    Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate or Rhythm Control in CRT (RHYTHMIC): Study rationale and protocol.
    Elliott MK; de Vere F; Mehta VS; Wijesuriya N; Strocchi M; Rajani R; Niederer S; Rinaldi CA
    Heart Rhythm O2; 2022 Dec; 3(6Part A):681-687. PubMed ID: 36589918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.
    Kamath GS; Cotiga D; Koneru JN; Arshad A; Pierce W; Aziz EF; Mandava A; Mittal S; Steinberg JS
    J Am Coll Cardiol; 2009 Mar; 53(12):1050-5. PubMed ID: 19298918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.
    Orlov MV; Gardin JM; Slawsky M; Bess RL; Cohen G; Bailey W; Plumb V; Flathmann H; de Metz K
    Am Heart J; 2010 Feb; 159(2):264-70. PubMed ID: 20152225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy.
    Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA
    Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive impact of pulmonary vein isolation on biventricular pacing in nonresponders to cardiac resynchronization therapy.
    Fink T; Rexha E; Schlüter M; Lemes C; Maurer T; Heeger CH; Reissmann B; Rottner L; Tönnis T; Ujeyl A; Krüger M; Portz N; Wohlmuth P; Mathew S; Ouyang F; Rillig A; Kuck KH; Metzner A
    Heart Rhythm; 2019 Mar; 16(3):416-423. PubMed ID: 30273766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing atrial fibrillation in the CRT patient: controversy or consensus?
    Upadhyay GA; Steinberg JS
    Heart Rhythm; 2012 Aug; 9(8 Suppl):S51-9. PubMed ID: 22521931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design.
    Hamdan MH; Freedman RA; Gilbert EM; Dimarco JP; Ellenbogen KA; Page RL
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1081-8. PubMed ID: 17038140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation-A Systematic Review of Systematic Review and Meta-Analysis.
    Zhang C; Wang XY; Lou L; Zhang X; Chen LL; Chen YX; Yang J
    Front Cardiovasc Med; 2021; 8():587297. PubMed ID: 35127840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Heart Fail Clin; 2017 Jan; 13(1):179-192. PubMed ID: 27886922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing: A real-world analysis of 37,450 patients followed by remote monitoring.
    Hsu JC; Birnie D; Stadler RW; Cerkvenik J; Feld GK; Birgersdotter-Green U
    Heart Rhythm; 2019 Jul; 16(7):983-989. PubMed ID: 31102750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to Improve Cardiac Resynchronization Therapy Benefit in Atrial Fibrillation Patients: Pulmonary Vein Isolation (and Beyond).
    Gianni C; Di Biase L; Mohanty S; Gökoğlan Y; Güneş MF; Al-Ahmad A; Burkhardt JD; Natale A
    Heart Fail Clin; 2017 Jan; 13(1):199-208. PubMed ID: 27886924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.